Loading...

World-Class Retina Care. Community-Based Caring.

Texas Retina Honors Founder Dr. Vaiser with Donation to Retina Foundation

Posted On August 21, 2024 / By / Posted in Blog

Texas Retina Honors Founder Dr. Vaiser with Donation to Retina Foundation

On behalf of the entire Texas Retina team, Gary Edd Fish, MD, recently presented a $2,000 donation to the Retina Foundation to honor the 90th birthday of one of Texas Retina’s founders,

read more
Posted On August 15, 2024 / By / Posted in Blog

Dr. Abbey Publishes Case Report on Management of Cystoid Macular Edema in Coats’ Disease

Texas Retina’s Ashkan M. Abbey, MD, recently co-authored a case report in the medical journal Ophthalmic Surgery, Lasers and Imaging Retina (OSLI Retina) on the use of an injectable flucocinolone implant for

read more
Posted On August 13, 2024 / By / Posted in Blog

Can Ozempic Affect Your Eyes or Vision?

Initially approved by the U.S. Food and Drug Administration (FDA) to help control blood sugar and treat type 2 diabetes, semaglutide (brand names Ozempic, Wegovy and Rybelsus) has also emerged as a

read more
Posted On August 12, 2024 / By / Posted in Blog

Dr. Wang Invited to Serve as Guest Lecturer at Ohio State University

Texas Retina’s Robert C. Wang will speak at The Ohio State University’s 7th Annual Retina Case Forum on Friday, August 16, 2024, as an invited guest lecturer. The event is a case-based

read more
Posted On August 6, 2024 / By / Posted in Blog

Recent Study Published in Journal of Clinical Oncology Highlights Importance of Prognostic Biomarker for Uveal Melanoma

The results of the Collaborative Ocular Oncology Study Number 2 (COOG2) were published in the July 2024 issue of the Journal of Clinical Oncology and validated the prognostic accuracy of the integrated

read more
Posted On July 25, 2024 / By / Posted in Blog

Dr. Wang Presented Initial Study Results of New Non-infectious Uveitis Treatment at ASRS 2024 Annual Meeting

Texas Retina’s Robert C. Wang, MD, presented “Safety and Efficacy of Brepocitinib, a TYK2/JAK1 Inhibitor, in Active Non-Infectious Uveitis: 24-Week Results from a 52-Week Phase II Study (NEPTUNE)” at the 2024 Annual

read more
Posted On July 24, 2024 / By / Posted in Blog

Dr. Abbey Presented Real-world Outcomes of Fluocinolone Acetonide Intravitreal Implant for Non-infectious Uveitis at ASRS 2024 Annual Meeting

Texas Retina’s Ashkan M. Abbey, MD, presented “36-month Optical Coherence Tomography Outcomes from CALM: A Registry Evaluating Treatment of Chronic Non-infectious Uveitis with the 0.18 mg Fluocinolone Acetonide Intravitreal Implant” at the

read more
Posted On / By / Posted in Blog

Dr. Anand and Dr. Abbey Receive Senior Honor Awards from the American Society of Retina Specialists (ASRS)

In recognition of their time and contributions to the scientific programs of the organization’s annual meetings, Texas Retina’s Rajiv Anand, MD, and Ashkan M. Abbey, MD, recently earned the Senior Honor Award

read more
Posted On July 17, 2024 / By / Posted in Blog

July is UV Safety Month — Debunking Seven Common Myths About Sunglasses

When most people think of UV protection, they think of their skin and sunscreen. Did you know that long-term exposure to bright sunlight may also increase your risk of eye disease? July

read more
Posted On June 10, 2024 / By / Posted in Blog

11 Tips to Protect Men’s Eye Health

June is Men’s Health Month. It was established to help bring awareness to health issues men face and to encourage them to take charge of their health. A number of retinal diseases can affect

read more